Current therapy for chronic hepatitis C: The role of direct-acting antivirals

G Li, E De Clercq - Antiviral research, 2017 - Elsevier
One of the most exciting developments in antiviral research has been the discovery of the
direct-acting antivirals (DAAs) that effectively cure chronic hepatitis C virus (HCV) infections …

[HTML][HTML] Plant-based natural products and extracts: Potential source to develop new antiviral drug candidates

E Thomas, LE Stewart, BA Darley, AM Pham, I Esteban… - Molecules, 2021 - mdpi.com
Viral infections are among the most complex medical problems and have been a major
threat to the economy and global health. Several epidemics and pandemics have occurred …

[HTML][HTML] Cynara cardunculus L.: Outgoing and potential trends of phytochemical, industrial, nutritive and medicinal merits

A Zayed, A Serag, MA Farag - Journal of Functional Foods, 2020 - Elsevier
Cynara cardunculus L. with its three botanical varieties are presented as potential food and
drug resources. Its young flower heads are commonly consumed as a principal part of …

Medicinal plant molecules against hepatitis C virus: Current status and future prospect

A Mandal, B Hazra - Phytotherapy Research, 2023 - Wiley Online Library
Hepatitis C virus (HCV), a global malady, causes acute and chronic hepatitis leading to
permanent liver damage, hepatocellular carcinoma, and death. Modern anti‐HCV therapies …

[HTML][HTML] Cynaropicrin: A comprehensive research review and therapeutic potential as an anti-hepatitis C virus agent

MF Elsebai, A Mocan, AG Atanasov - Frontiers in pharmacology, 2016 - frontiersin.org
The different pharmacologic properties of plants-containing cynaropicrin, especially
artichokes, have been known for many centuries. More recently, cynaropicrin exhibited a …

Promotion of HeLa cells apoptosis by cynaropicrin involving inhibition of thioredoxin reductase and induction of oxidative stress

T Liu, J Zhang, X Han, J Xu, Y Wu, J Fang - Free Radical Biology and …, 2019 - Elsevier
Cancer is considered as one of the highly mortal diseases globally. This is largely due to the
lack of efficacious medicines for tumors, and thus development of potent anticancer agents …

Valorization, extraction optimization and technology advancements of artichoke biowastes: Food and non-food applications

A Zayed, MA Farag - Lwt, 2020 - Elsevier
Large quantities of non-edible parts of the artichoke plant (Cynara cardunculus L.)
comprising leaves, stems, roots, bracts, and seeds are discarded annually during industrial …

[HTML][HTML] Host-derived circular RNAs display proviral activities in Hepatitis C virus-infected cells

TC Chen, M Tallo-Parra, QM Cao, S Kadener… - PLoS …, 2020 - journals.plos.org
Viruses subvert macromolecular pathways in infected host cells to aid in viral gene
amplification or to counteract innate immune responses. Roles for host-encoded, noncoding …

Current status and future development of infectious cell-culture models for the major genotypes of hepatitis C virus: essential tools in testing of antivirals and emerging …

S Ramirez, J Bukh - Antiviral research, 2018 - Elsevier
In this review, we summarize the relevant scientific advances that led to the development of
infectious cell culture systems for hepatitis C virus (HCV) with the corresponding challenges …

[HTML][HTML] Identification of a flavonoid isolated from plum (Prunus domestica) as a potent inhibitor of Hepatitis C virus entry

M Bose, M Kamra, R Mullick, S Bhattacharya, S Das… - Scientific Reports, 2017 - nature.com
Hepatitis C virus (HCV) infection is a major cause of chronic liver diseases that often
requires liver transplantation. The standard therapies are limited by severe side effects …